Project title: ELECTRONIC EYEGLASSES FOR TREATMENT OF AMBLYOPIA IN CHILDREN

Company name : OPHTHOCARE LTD.

TECHNOLOGICAL FIELD
Ophthalmology, Medical devices

KEY WORDS
Amblyopia, Lazy Eye, Occluder,
Electronic Eyeglasses, Eye Patching

PROJECT SUMMARY
OphthoCare has developed unique electronic glasses (Liquid
Crystal Glasses- LCG) for treatment of ocular disorders and nerve
stimulation applications.
The first product, intended for treating Amblyopia (lazy eye) in
children, has successfully completed clinical trials with very
good results. Pre -clinical studies on additional applications
are still ongoing.
Company products are based on unique IP, backed by full licensing
of relevant prior art. Strong in house-research and development
capabilities facilitates R&D.

Amblyopia, also named 'Lazy Eye Syndrome', is a medical disorder
common in about 3-5% of children and should be treated at early
ages of childhood.
The most commonly used treatment is enforcement of utilization of
the weak eye by patching of the sound eye. This treatment is
problematic and highly disliked by the children. As a result,
treatment success rate is low (less than 50%). The outcome is
that children remain with their disorder for life.
The LCG provide an alternative therapy, highly preferred by
parents and children alike. An electronic LC shutter,
incorporated into the optical refractive lens, performs short
periodical occlusions, shifting the visual center activity
towards the neglected eye. A bed side "compliance meter"
indicates wear time and provides valuable compliance information
to parents and physicians.
The LCG is expected to achieve high compliance and better success
rates in the treatment of Amblyopia.

ENTREPRENEURS
Mr. Rafi Herzog - (B.Sc, MBA),
extensive experience in management, product development,
marketing and regulatory issues.
Mr. Yossi Gross - (B.Sc), leading
Israeli entrepreneur involved in large number of medical
companies.
Dr. Omry Ben Ezra - MD with experience
in medical research.
Prof. David Ben Ezra - Medical advisor,
Director, Paediatric Ophthalmology Unit, Hadassah Hospital,
Jerusalem, Israel

PROJECT STATUS
Clinical study completed successfully. FDA approved (510K). Ready
for large scale production and world-wide sales by the first
quarter of 2006. Continuous R&D towards new applications.

COOPERATION REQUIRED
* Strategic partners from the field of ophthalmology for
world-wide marketing, distribution and sales.
* Second round investment to facilitate production, sales and
ongoing research activities.

-----------------------------------------------------
TEL: 972-9-7724280; FAX: 972-9-7716918; E-MAIL:
rherzog@ophthocare.com WEB: www.ophthocare.com

Request for more information, about this project.

Note - you have to be registered in this server to request information. If you haven't done so yet, please:
Register in this server and your requests will be forwarded to the developer, who will contact you directly

List of projects that you already requested more information about